Parents’ views on future clinical trials

We asked parents if they would consider involving their children in future medical research if the opportunity was offered.

All parents said that they would “consider it”. Some parents had already enrolled their children in more than one trial.

However, as with their previous decision about enrolling their children, parents said they would be considering the risk and benefit to their children, the demands of the trial in terms of time and the wider benefits of the trial for other children and medical science. They said they would want good, clear information about the trial and would want to be sure their children were happy to take part and understood what was expected of them. They would want to be aware of any potential side effects, and that any treatment such as medication was safe and previously tested.

Knowing that a drug had been tested and safe for their children to take was important to all parents. Most parents said that they would not enrol their children in trials if the treatments or drugs had not been previously tested for safety.

Even though Ruth had decided not to enrol her son in a swine flu vaccine trial, she would…

Age at interview 38

Gender Female

View profile

Tina says that having good information and being able to ask questions would certainly make a…

Gender Female

View profile

However, as Alison suggests, having good information should also include the possibility of a trial showing that a new treatment has no beneficial effect. Alison refers to a trial that her son took part in during his stay in neonatal care. The doctors and nurses were very positive about the trial and so when the trial showed no beneficial effect of an antibiotic to reduce sepsis in very premature babies, it was slightly disappointing. This is important and researchers may need to consider how to manage parents’ expectations at the beginning of a trial.

Alisons son took part in a trial that showed no beneficial effects; she feels that parents…

Age at interview 39

Gender Female

View profile

Randomised trials are done when we don’t know which treatment is best, in other words when the relative merits and disadvantages of different treatments are uncertain. It is important to realise that, on average, new treatments are as likely to turn out worse as they are to turn out better than existing treatments. This means that, going in a trial, everyone, regardless of which of the treatment groups the computer allocates them to, must have similar chances of a good outcome. If, despite the treatment uncertainties that the trial has been designed to address, people would strongly prefer one of the treatments being compared, they should not volunteer for the trial.

In addition to sufficient information and being able to ask questions, most parents felt it was important to include their children in the decision where possible.

Steve says it is his sons choice to take part, or not, in a trial, although he hopes that his…

Age at interview 49

Gender Male

View profile

Lena would consider other vaccine trials for her children if there was sufficient information and…

Age at interview 44

Gender Female

View profile

Jane would consider other trials for her daughter if they could help other children with diabetes…

Age at interview 41

Gender Female

View profile

Taking part in clinical trials helps improve treatment, but his son would have the final decision.

Age at interview 29

Gender Male

View profile

Most parents we talked to would consider other trials if there was minimal discomfort to their children and if there were benefits for their children’s health. For trials that were more invasive such as taking medication or required lots of tests, some parents said they would like to find out from other trial participants what their experience had been before making a decision to enrol their children

Talking to other trial participants is something Nikki and Chris would like to do if they were to…

Age at interview 38

Gender Male

View profile

John has enrolled his daughter in various trials and would consider other trials depending on how…

Age at interview 35

Gender Male

View profile

Linda would consider another trial especially if it might benefit her daughter.

Age at interview 43

Gender Female

View profile

Contributing to medical knowledge and helping other children were also important to parents although some parents were unconvinced about their children taking part in randomised placebo-controlled trials. (See ‘Understanding allocation (randomisation) to a treatment comparison group’ and ‘Why do we have clinical trials in children and young people’ for explanations about different trial designs.)

Vicky would consider other trials if it would help her daughter and other children with diabetes…

Age at interview 39

Gender Female

View profile

Lucinda supports research and was quite surprised that childhood migraine hadnt been researched.

Age at interview 37

Gender Female

View profile

Although Catherine is supportive of clinical trials, she is less convinced about enrolling her…

Age at interview 27

Gender Female

View profile

Most parents we talked to would support their children if they wanted to take part in trials in the future, although they also recognised that making a decision for yourself and making a decision for your child is a very different thing.

Even though Julies son was not eligible to take part in a trial, she would consider another…

Age at interview 45

Gender Female

View profile

Julie would support her son if he wanted to take part in a trial in the future, and explain that…

Age at interview 45

Gender Female

View profile

Taking part in other trials would depend on the benefit for Rachel’s children and the benefit to…

Age at interview 35

Gender Female

View profile

Having good rapport with the research team, doctors and nurses involved in the trial and treatment of their children were also important factors in making parents feel positive about future research opportunities.

The continuity and the approachability of nurses were important to Nikki and Chris and helped…

Age at interview 38

Gender Male

View profile

Sandra and her 9 year old daughter were invited to take part in a study to improve knowledge and prognosis of juvenile dermatomyositis (JDM). JDM is a very rare condition that affects children under the age of 18 and affects approximately 2 children per million. It is an autoimmune disease where the body’s own immune system attacks the body, skin, muscles, and internal organs.

Sandra hadnt come across clinical trials or medical research before, but she wanted to take part…

Age at interview 46

Gender Female

View profile

It is important that families who want to contribute to increasing medical knowledge have the…

Gender Male

View profile